DekaBank Deutsche Girozentrale
ARLZ

DekaBank Deutsche Girozentrale’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed – – 1251
2017
Q4 		$0 Hold
100
– – ﹤0.01% 1043
2017
Q3 		$0 Hold
100
– – ﹤0.01% 1065
2017
Q2 		$0 Buy
+100
New +$144 ﹤0.01% 1085
2016
Q3 		– Sell
-100
Closed – – 1084
2016
Q2 		$0 Hold
100
– – ﹤0.01% 1104
2016
Q1 		$0 Buy
+100
New +$515 ﹤0.01% 1148

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ARLZ Position: Q1 2018 in Review

DekaBank Deutsche Girozentrale sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q1 2018, closing a stake of 100 shares.

DekaBank Deutsche Girozentrale first reported a position in ARLZ in Q1 2016 and held it in 5 quarters. The position peaked at $0 in Q4 2017. 56 funds tracked by Wall St. Rank hold ARLZ as of Q1 2018.

  • DekaBank Deutsche Girozentrale reported no remaining Aralez Pharmaceuticals Inc. position as of Q1 2018 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 100 Aralez Pharmaceuticals Inc. shares in Q1 2018.
  • DekaBank Deutsche Girozentrale first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 5 quarters.
  • DekaBank Deutsche Girozentrale's Aralez Pharmaceuticals Inc. position peaked at $0 in Q4 2017.
  • 56 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q1 2018.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2018, filed 3 May 2018.